Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > ULURU Inc. Announces Development Partnership With a Leading Consumer Pharmaceutical Company to Develop a Range of Products.

Abstract:
- Initial development focused on utilizing our nanoparticle elastic gel to improve topical product performance -

ULURU Inc. Announces Development Partnership With a Leading Consumer Pharmaceutical Company to Develop a Range of Products.

ADDISON, TX | Posted on July 11th, 2007

ULURU Inc. (OTC Bulletin Board: ULUR) today announced that it has commenced the development of a range of consumer pharmaceutical products under a development agreement signed with a major consumer pharmaceutical company.

The initial developments are focused on utilizing our nanoparticle
elastic adhesive gel, which offers the potential to significantly extend
the time that a flexible film stays in contact with the skin, to release
active compounds. Under the terms of the agreement ULURU will receive
payments for the development activities and has granted its development
partner a period of exclusivity to enter a potential licensing agreement.

Commenting on the agreement Kerry P. Gray, President and CEO of ULURU
Inc., stated "This is an important validation of our nanoparticle elastic
gel technology. Considerable interest has been expressed in this technology
by both consumer product and dermatology companies as the gel offers the
potential to extend the delivery of actives to the skin surface. Both the
gel technology and our erodible film technology give us the potential to
develop a range of differentiated consumer pharmaceutical products with a
significant period of patent protection. We continue to explore extensions
of our technology applications into the consumer pharmaceutical market as
this offers the potential to accelerate product revenue."

The nanoparticle elastic gel forms a transparent adhesive film that can
be spread on intact skin or superficial non-exudating wounds. The film can
be applied to irregular surfaces such as joints without impairing movement
and deliver active compounds for extended periods of time. Potential uses
of the elastic gel include treatment of acne, psoriasis, skin irritation,
scar management and cold sores.

####

About ULURU Inc.
ULURU Inc. is an emerging specialty pharmaceutical company focused on
the development of a portfolio of wound management, plastic surgery and
oral care products to provide patients and consumers improved clinical
outcomes through controlled delivery utilizing its innovative transmucosal
delivery system and Hydrogel Nanoparticle Aggregate technology. For further
information about ULURU Inc., please visit our website at
http://www.uluruinc.com .

This press release contains certain statements that are forward-looking
within the meaning of Section 27a of the Securities Act of 1933, as
amended, including but not limited to statements made relating to potential
licensing arrangements, potential uses for our nanoparticle elastic gel
technology, interest expressed in this technology, and the potential for
accelerated product revenue. These statements are subject to numerous risks
and uncertainties, including but not limited to the risk factors detailed
in the Company's Annual Report on Form 10-KSB for the year ended December
31, 2006, Quarterly Report on Form 10-QSB for the quarter ended March 31,
2007 and other reports filed by us with the Securities and Exchange
Commission.

For more information, please click here

Contacts:
Kerry P. Gray
President & CEO
Terry K. Wallberg
Vice President & CFO
(214) 905-5145

Copyright © PR Newswire Association LLC.

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Nanomedicine

Nano-kirigami: 'Paper-cut' provides model for 3D intelligent nanofabrication July 13th, 2018

UMBC researchers develop nanoparticles to reduce internal bleeding caused by blast trauma July 13th, 2018

Researchers identify cost-cutting option in treating nail fungus with nanotechnology: GW researcher Adam Friedman, M.D., studied the potential use of nitric oxide-releasing nanoparticles to improve onychomycosis treatment July 11th, 2018

New sensor technology enables super-sensitive live monitoring of human biomolecules July 3rd, 2018

Announcements

World's fastest man-made spinning object could help study quantum mechanics July 20th, 2018

Relax, just break it July 20th, 2018

Future electronic components to be printed like newspapers July 20th, 2018

The relationship between charge density waves and superconductivity? It's complicated July 19th, 2018

Alliances/Trade associations/Partnerships/Distributorships

Leti and Oscaro Partner on Letiís New Low-Power, Low-Cost Transceiver to Track Parcels July 12th, 2018

Leti and Soitec Launch a New Substrate Innovation Center to Develop Engineered Substrate Solutions: Industry-inclusive hub promotes early collaboration and learning from substrate to system level July 11th, 2018

Leti & Partners Launch Pilot Program to Assess New Perception Sensors for Autonomous Vehicles July 5th, 2018

Powering the 21st Century with Integrated Photonics: UCSB-Led Team Selected for Demonstration of a Novel Waveguide Platform Which is Transparent Throughout the MWIR and LWIR Spectral Bands June 19th, 2018

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project